NASDAQ : KOD
Kodiak Sciences Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 100.4 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 6.30B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 47.73M | 52.02M | 60.75M | 71.02M | 73.79M | 49.71M |
| Research & Development | 200.60M | 182.37M | 126.09M | 206.30M | 267.59M | 217.34M |
| Operating Expenses | 248.33M | 234.39M | 186.85M | 277.32M | 341.38M | 267.05M |
| Operating Income | -248.33M | -234.39M | -186.85M | -277.32M | -341.38M | -267.05M |
| Interest Expense | -13.00K | -18.00K | -47.00K | |||
| Interest & Investment Income | 4.57M | 4.52M | 11.15M | 16.73M | 7.07M | 298.00K |
| Other Non Operating Income (Expenses) | -144.00K | -96.00K | -506.00K | -736.00K | -565.00K | -165.00K |
| EBT Excluding Unusual Items | -243.90M | -229.97M | -176.21M | -261.34M | -334.89M | -266.96M |
| Gain (Loss) on Sale of Investments | 846.00K | 1.07M | -25.00K | |||
| Pretax Income | -241.99M | -229.97M | -176.21M | -260.49M | -333.82M | -266.99M |
| Net Income | -241.99M | -229.97M | -176.21M | -260.49M | -333.82M | -266.99M |
| Net Income to Common | -241.99M | -229.97M | -176.21M | -260.49M | -333.82M | -266.99M |
| Shares Outstanding (Basic) | 57.95M | 53.21M | 52.58M | 52.41M | 52.25M | 51.79M |
| Shares Outstanding (Diluted) | 57.95M | 53.21M | 52.58M | 52.41M | 52.25M | 51.79M |
| EPS (Basic) | -4.18 | -4.32 | -3.35 | -4.97 | -6.39 | -5.16 |
| EPS (Diluted) | -4.18 | -4.32 | -3.35 | -4.97 | -6.39 | -5.16 |
| Free Cash Flow | -159.90M | -136.51M | -117.72M | -195.61M | -253.82M | -245.57M |
| Free Cash Flow Per Share | -2.76 | -2.57 | -2.24 | -3.73 | -4.86 | -4.74 |
| EBITDA | -230.98M | -216.06M | -168.14M | -259.02M | -337.58M | -266.05M |
| D&A For EBITDA | 17.35M | 18.33M | 18.71M | 18.30M | 3.80M | 1.00M |
| EBIT | -248.33M | -234.39M | -186.85M | -277.32M | -341.38M | -267.05M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 125.90M | 209.86M | 168.07M | 285.51M | 190.43M | 731.51M |
| Short-Term Investments | 288.50M | |||||
| Cash & Short-Term Investments | 125.90M | 209.86M | 168.07M | 285.51M | 478.93M | 731.51M |
| Prepaid Expenses | 5.46M | 4.95M | 3.86M | 3.80M | 7.07M | 3.30M |
| Total Current Assets | 131.36M | 214.82M | 171.94M | 289.31M | 486.00M | 734.81M |
| Property, Plant & Equipment | 110.61M | 121.86M | 148.73M | 175.02M | 115.75M | 108.07M |
| Other Long-Term Assets | 14.85M | 14.85M | 14.91M | 15.04M | 64.87M | 61.34M |
| Total Assets | 256.81M | 351.53M | 335.58M | 479.37M | 666.63M | 904.22M |
| Accounts Payable | 12.64M | 12.86M | 3.92M | 13.61M | 9.13M | 12.43M |
| Accrued Expenses | 30.32M | 20.61M | 11.03M | 18.35M | 33.44M | 48.32M |
| Current Portion of Leases | 9.81M | 12.06M | 10.63M | 9.77M | 9.93M | 3.93M |
| Total Current Liabilities | 52.77M | 45.53M | 25.57M | 41.73M | 52.50M | 64.68M |
| Long-Term Leases | 42.95M | 47.12M | 59.72M | 71.86M | 77.81M | 76.06M |
| Other Long-Term Liabilities | 100.00M | 101.50M | 100.00M | 100.00M | 100.16M | 100.15M |
| Total Liabilities | 195.72M | 194.15M | 185.29M | 213.59M | 230.46M | 240.90M |
| Common Stock | 6.00K | 6.00K | 5.00K | 5.00K | 5.00K | 5.00K |
| Additional Paid-In Capital | 1.74B | 1.72B | 1.48B | 1.42B | 1.33B | 1.22B |
| Retained Earnings | -1.68B | -1.56B | -1.33B | -1.15B | -892.04M | -558.22M |
| Comprehensive Income & Other | -1.31M | |||||
| Total Common Equity | 61.10M | 157.38M | 150.29M | 265.78M | 436.17M | 663.32M |
| Shareholders' Equity | 61.10M | 157.38M | 150.29M | 265.78M | 436.17M | 663.32M |
| Total Liabilities & Equity | 256.81M | 351.53M | 335.58M | 479.37M | 666.63M | 904.22M |
| Total Debt | 52.76M | 59.18M | 70.34M | 81.63M | 87.73M | 80.00M |
| Net Cash (Debt) | 73.15M | 150.68M | 97.73M | 203.88M | 391.20M | 651.51M |
| Net Cash Per Share | 1.26 | 2.83 | 1.86 | 3.89 | 7.49 | 12.58 |
| Filing Date Shares Outstanding | 62.72M | 61.73M | 52.63M | 52.34M | 52.06M | 51.57M |
| Total Common Shares Outstanding | 62.70M | 61.64M | 52.61M | 52.34M | 52.05M | 51.46M |
| Working Capital | 78.59M | 169.28M | 146.36M | 247.58M | 433.51M | 670.13M |
| Book Value Per Share | 0.97 | 2.55 | 2.86 | 5.08 | 8.38 | 12.89 |
| Tangible Book Value | 61.10M | 157.38M | 150.29M | 265.78M | 436.17M | 663.32M |
| Tangible Book Value Per Share | 0.97 | 2.55 | 2.86 | 5.08 | 8.38 | 12.89 |
| Machinery | 42.71M | 42.37M | 41.75M | 14.73M | 4.89M | |
| Construction In Progress | 5.16M | 4.20M | 4.37M | 4.52M | 37.81M | |
| Leasehold Improvements | 96.51M | 96.53M | 96.53M | 43.48M | 1.28M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -241.99M | -229.97M | -176.21M | -260.49M | -333.82M | -266.99M |
| Depreciation & Amortization | 25.58M | 26.32M | 26.71M | 25.95M | 11.00M | 8.71M |
| Other Amortization | 53.00K | 53.00K | ||||
| Loss (Gain) From Sale of Assets | -8.00K | 120.00K | ||||
| Asset Writedown & Restructuring Costs | 1.91M | |||||
| Loss (Gain) From Sale of Investments | -846.00K | -1.07M | 25.00K | |||
| Stock-Based Compensation | 51.09M | 58.86M | 60.21M | 88.56M | 106.03M | 61.38M |
| Other Operating Activities | 20.00K | 20.00K | 355.00K | 6.00K | -616.00K | |
| Change in Accounts Payable | 7.19M | 8.07M | -9.69M | 5.60M | 1.66M | -2.09M |
| Change in Other Net Operating Assets | -389.00K | -1.22M | -18.69M | -12.95M | 10.30M | 16.52M |
| Operating Cash Flow | -158.50M | -136.01M | -117.32M | -154.18M | -206.46M | -182.27M |
| Capital Expenditures | -1.40M | -506.00K | -400.00K | -41.43M | -47.36M | -63.30M |
| Investment in Securities | 290.65M | -289.77M | 24.50M | |||
| Other Investing Activities | -355.00K | 616.00K | ||||
| Investing Cash Flow | -1.40M | -506.00K | -755.00K | 249.23M | -336.51M | -38.80M |
| Issuance of Common Stock | 181.94M | 178.30M | 501.00K | 242.00K | 1.94M | 8.23M |
| Other Financing Activities | -303.00K | -211.00K | -49.00K | -45.00K | ||
| Financing Cash Flow | 181.64M | 178.30M | 501.00K | 31.00K | 1.90M | 8.18M |
| Net Cash Flow | 21.74M | 41.79M | -117.57M | 95.07M | -541.08M | -212.89M |
| Free Cash Flow | -159.90M | -136.51M | -117.72M | -195.61M | -253.82M | -245.57M |
| Free Cash Flow Per Share | -2.76 | -2.57 | -2.24 | -3.73 | -4.86 | -4.74 |
| Levered Free Cash Flow | -58.39M | -44.38M | -47.34M | -107.60M | -165.60M | -128.65M |
| Unlevered Free Cash Flow | -58.39M | -44.38M | -47.34M | -107.59M | -165.59M | -128.62M |
| Cash Interest Paid | 13.00K | 18.00K | 22.00K | |||
| Change in Working Capital | 6.80M | 6.85M | -28.39M | -7.36M | 11.96M | 14.43M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 6.22B | 1.73B | 522.39M | 158.95M | 372.50M | 4.35B |
| Enterprise Value | 6.15B | 1.72B | 397.96M | -103.24M | -77.06M | 3.63B |
| Last Close Price | 99.18 | 27.96 | 9.95 | 3.04 | 7.16 | 84.78 |
| PB Ratio | 101.79 | 11.01 | 3.48 | 0.60 | 0.85 | 6.56 |
| P/TBV Ratio | 101.82 | 11.01 | 3.48 | 0.60 | 0.85 | 6.56 |
| Debt / Equity Ratio | 0.86 | 0.38 | 0.47 | 0.31 | 0.20 | 0.12 |
| Net Debt / Equity Ratio | -1.20 | -0.96 | -0.65 | -0.77 | -0.90 | -0.98 |
| Net Debt / EBITDA Ratio | 0.32 | 0.70 | 0.58 | 0.79 | 1.16 | 2.45 |
| Net Debt / FCF Ratio | 0.46 | 1.10 | 0.83 | 1.04 | 1.54 | 2.65 |
| Quick Ratio | 2.39 | 4.61 | 6.57 | 6.84 | 9.12 | 11.31 |
| Current Ratio | 2.49 | 4.72 | 6.72 | 6.93 | 9.26 | 11.36 |
| Return on Equity (ROE) | -368.37% | -149.49% | -84.70% | -74.22% | -60.72% | -35.04% |
| Return on Assets (ROA) | -60.45% | -42.64% | -28.66% | -30.25% | -27.16% | -16.93% |
| Return on Capital Employed (ROCE) | -121.70% | -76.60% | -60.30% | -63.40% | -55.60% | -31.80% |
| Earnings Yield | -4.21% | -13.27% | -33.73% | -163.88% | -89.62% | -6.14% |
| FCF Yield | -2.57% | -7.88% | -22.54% | -123.06% | -68.14% | -5.65% |
| Buyback Yield / Dilution | -9.96% | -1.19% | -0.32% | -0.32% | -0.89% | -13.22% |